non variceal upper gastrointestinal bleeding oral iron supplement, anemia, non variceal upper gastrointestinal bleeding
Conditions
Interventions
Ferrous fumarate (200 mg/tab) three times per day for 6 week after episode of upper gastrointestinal bleeding,no intervention
Experimental Drug,No Intervention No treatment
iron supplement,control group
Sponsors
Hatyai Hospital Foundation
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. non variceal upper gastrointestinal bleeding who admited in hospital 2. age between 18-75 years 3. who was diagnosed with anemia secondary to UGIB on the day of inclusion (Anemia was defined according to the definitions of the World Health Organization (WHO): hemoglobin level lower than 12 g/dL for women and 13 g/dL for men)
Exclusion criteria
Exclusion criteria: (1) pregnant or nursing mothers (2) pathologies that could influence anemia progression (including chronic renal failure, decompensated cirrhosis, cancer, presence of systemic inflammatory response syndrome [SIRS] or sepsis) (3) history of overt UGIB within 3 months prior to inclusion (4) previous iron supplementation intake within 3 months (5) history of chronic anemia or treatment of erythropoietin (6) contraindication of iron use (e.g., hemochromatosis, thalassemia major, and history of allergy to oral iron medicine)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum hemoglobin level 6 week after upper gastrointestinal bleeding g/dL | — |
Secondary
| Measure | Time frame |
|---|---|
| serum iron 6 week after upper gastrointestinal bleeding microgram/dL,TIBC 6 week after upper gastrointestinal bleeding microgram/dL,Serum ferritin 6 week after upper gastrointestinal bleeding nanogram/dL,adverse drugs reaction of iron supplement 6 week after upper gastrointestinal bleeding times | — |
Countries
Thailand
Contacts
Public ContactArunchai Change
Hatyai Hospital
Outcome results
None listed